A Novel Combination of Serum Markers in a Multivariate Model to Help Triage Patients Into “Low-” and “High-Risk” Categories for Prostate Cancer

BackgroundAlmost 50,000 men in the United Kingdom (UK) are diagnosed each year with prostate cancer (PCa). Secondary referrals for investigations rely on serum prostate-specific antigen (PSA) levels and digital rectal examination. However, both tests lack sensitivity and specificity, resulting in un...

Full description

Bibliographic Details
Main Authors: Christopher J. McNally, Joanne Watt, Mary Jo Kurth, John V. Lamont, Tara Moore, Peter Fitzgerald, Hardev Pandha, Declan J. McKenna, Mark W. Ruddock
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.837127/full